Long-Term Monitoring of Individuals With Chronic Obstructive Pulmonary Disease Using Digital Health Technology: Qualitative Study

被引:0
|
作者
Chien, Shih-Ying [1 ,2 ,3 ]
Hu, Han-Chung [4 ,5 ]
Cho, Hsiu-Ying [5 ]
机构
[1] Chang Gung Univ, Dept Ind Design, 259,Wen Hwa 1st Rd, Taoyuan 333, Taiwan
[2] Natl Yang Ming Chiao Tung Univ, Sch Med, Dept Publ Hlth & Med Humanities, Hsinchu, Taiwan
[3] Linkou Chang Gung Mem Hosp CGMH, Dept Phys Med & Rehabil, Taoyuan, Taiwan
[4] Linkou Chang Gung Mem Hosp, Dept Thorac Med, Taoyuan, Taiwan
[5] Linkou Chang Gung Mem Hosp, Dept Resp Therapy, Taoyuan, Taiwan
关键词
digital health; chronic obstructive pulmonary disease; digital health technology; barriers and facilitators; Taiwan; OF-LIFE; REHABILITATION; HOSPITALIZATION; HYPERINFLATION; INTERVENTIONS; EXACERBATION; BARRIERS; OUTCOMES; DYSPNEA;
D O I
10.2196/63660
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Digital health adoption in clinical practice has been widespread, yet there remains further potential for optimizing care specifically for chronic obstructive pulmonary disease (COPD). This study therefore conducted qualitative research involving 35 health care professionals from a range of hospitals in Taiwan. Objective: This study aims to investigate barriers and facilitators related to the implementation of digital health technology (DHT) in the long-term monitoring of individuals with COPD based on clinical experiences in Taiwan. The perspectives of Taiwanese health care professionals provided valuable insights into the challenges and opportunities associated with using DHT for the management and enhancement of respiratory rehabilitation and long-term monitoring of patients with COPD. Methods: Several key themes related to the development of DHT were identified. Barriers encompassed concerns pertaining to digital safety, insurance coverage, constraints related to medical resources, and the presence of a digital divide. Facilitators included the potential for cost reduction, personalized prescriptions, and instilling motivation in users. Results: To enhance the acceptance and use of DHT, embracing a user-centered approach that prioritizes the distinct needs of all parties involved is recommended. Moreover, optimizing and leveraging the effective use of DHT in managing the health of individuals with COPD promises to deliver care characterized by greater precision and efficiency. Conclusions: Overall, the benefits of using DHT for the long-term care of patients with COPD outweigh the disadvantages. After the COVID-19 pandemic, there has been an increased emphasis in Taiwan on the effectiveness of DHT in managing chronic diseases. Relevant studies including this paper have suggested that web-based exercise management systems could benefit patients with COPD in rehabilitation and tracking. Our findings provide meaningful directions for future research endeavors and practical implementation. By addressing identified barriers and capitalizing on facilitators, advancements can be made in the development and use of DHT, especially in overcoming challenges such as information security and operational methods. The implementation of the recommended strategies will likely lead to improved COPD care outcomes.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] A qualitative study of chronic obstructive pulmonary disease patient perceptions of the barriers and facilitators to adopting digital health technology
    Slevin, Patrick
    Kessie, Threase
    Cullen, John
    Butler, Marcus W.
    Donnelly, Seamas C.
    Caulfield, Brian
    DIGITAL HEALTH, 2019, 5
  • [2] A STUDY OF LONG-TERM EFFECT OF THERAPY IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE
    EMIRGIL, C
    SOBOL, BJ
    NORMAN, J
    MOSKOWITZ, E
    GOYAL, P
    WADHWANI, B
    VARBLE, A
    WALDIE, J
    WEINHEIMER, B
    AMERICAN JOURNAL OF MEDICINE, 1969, 47 (03): : 367 - +
  • [3] LONG-TERM AZITHROMYCIN TREATMENT IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE
    Kostadinova, Vanya
    Radkov, Yordan
    Stoeva, Temenuga
    Miteva, Darina
    JOURNAL OF IMAB, 2020, 26 (03): : 3259 - 3266
  • [4] Long-term macrolide therapy in chronic obstructive pulmonary disease
    Parameswaran, Ganapathi Iyer
    Sethi, Sanjay
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2014, 186 (15) : 1148 - 1152
  • [5] Long-Term Outcome of Chronic Obstructive Pulmonary Disease: A Review
    Jo, Yong Suk
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2022, 85 (04) : 289 - 301
  • [6] Social Participation and Associated Factors in Individuals with Chronic Obstructive Pulmonary Disease on Long-Term Oxygen Therapy
    Evangelista, Deborah Gollner
    Malaguti, Carla
    Meirelles, Felipe de Azevedo
    da Silva de Jesus, Luciana Angelica
    Jose, Anderson
    Cabral, Leandro Ferracini
    Silva, Vanessa Cardoso
    Cabral, Laura Alves
    Oliveira, Cristino Carneiro
    COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2021, 18 (06) : 630 - 636
  • [7] Digital health in chronic obstructive pulmonary disease
    Long Huanyu
    Li Shurun
    Chen Yahong
    慢性疾病与转化医学(英文), 2023, 09 (02)
  • [8] The effect of long-term treatment with erdosteine on chronic obstructive pulmonary disease: The equalife study
    Moretti, M
    Bottrighi, P
    Dallari, R
    Da Porto, R
    Dolcetti, A
    Grandi, P
    Garuti, G
    Guffanti, E
    Roversi, P
    De Gugliemo, M
    Potena, A
    DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH, 2004, 30 (04) : 143 - 152
  • [9] Use of long-term macrolide therapy in chronic obstructive pulmonary disease
    Ramos, Frederick L.
    Criner, Gerard J.
    CURRENT OPINION IN PULMONARY MEDICINE, 2014, 20 (02) : 153 - 158
  • [10] Long-term safety of roflumilast in the treatment of chronic obstructive pulmonary disease
    Bethke, TD
    Bateman, ED
    van Noord, JA
    Steffen, H
    Schmid-Wirlitsch, C
    Bredenbroeker, D
    Timar, M
    CHEST, 2004, 126 (04) : 805S - 805S